Table 5 Diagnoses with numbers of QIs and QIs revealing non-adherence to the guidelines
Diagnosis | n of cases with diagnosis (number of QIs) | n of QIs revealing non-adherent treatment | % QIs revealing non-adherent treatment (95% CI) | |
|---|---|---|---|---|
Arterial hypertension | 424 (424) | 69 | 16.3 | (12.8-19.9) |
Diabetes mellitus type 2 | 174 (174) | 8 | 4.6 | (1.5-7.7) |
Heart failure | 41 (89) | 27 | 30.3 | (20.8-39.9) |
β-Blocker | 41 (41) | 15 | 36.6 | (21.8-51.3) |
RAAS-I | 41 (41) | 8 | 19.5 | (7.4-31.6) |
Aldo-A in NYHA III/IV | 7 (7) | 4 | 57.1 | (20.5-93.8) |
Atrial fibrillation | 106 (106) | 15 | 14.2 | (7.5-20.8) |
Cardiovascular disease | 177 (431) | 86 | 20.0 | (16.2-23.7) |
Statin | 177 (177) | 53 | 29.9 | (23.2-36.7) |
Platelet aggregation inhibitors | 177 (177) | 12 | 6.8 | (3.1-10.5) |
β-blocker after myocardial infarction | 77 (77) | 21 | 27.3 | (17.3-37.2) |
Total* | 922 (1224) | 205 | 16.8 | (14.7-18.8) |